RCM
PFE icon

Riverhead Capital Management’s Pfizer PFE Stock Holding History

Riverhead Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$15.9M Sell
465,403
-101,960
-18% -$3.71M 0.59% 22
2019
Q2 		$23.3M Sell
567,363
-60,494
-10% -$2.4M 0.86% 6
2019
Q1 		$25.3M Buy
627,857
+31,727
+5% +$1.27M 1.03% 4
2018
Q4 		$24.7M Buy
596,130
+62,762
+12% +$2.61M 1.11% 4
2018
Q3 		$22.3M Buy
533,368
+41,139
+8% +$1.58M 0.81% 9
2018
Q2 		$16.9M Buy
492,229
+28,943
+6% +$989K 0.67% 19
2018
Q1 		$15.6M Buy
463,286
+62,039
+15% +$2.13M 0.66% 20
2017
Q4 		$13.8M Buy
401,247
+62,482
+18% +$2.13M 0.58% 27
2017
Q3 		$11.5M Buy
338,765
+55,809
+20% +$1.79M 0.54% 34
2017
Q2 		$9.02M Buy
282,956
+61,434
+28% +$1.94M 0.45% 39
2017
Q1 		$7.19M Buy
221,522
+65,573
+42% +$2.07M 0.4% 46
2016
Q4 		$4.8M Sell
155,949
-190,856
-55% -$5.83M 0.3% 81
2016
Q3 		$11.1M Buy
346,805
+322,692
+1,338% +$10.8M 0.72% 23
2016
Q2 		$1.2M Sell
24,113
-1,107,841
-98% -$35.4M 0.04% 390
2016
Q1 		$31.8M Buy
1,131,954
+1,041,998
+1,158% +$29.8M 0.45% 49
2015
Q4 		$2.75M Sell
89,956
-810,827
-90% -$25.5M 0.04% 452
2015
Q3 		$26.8M Sell
900,783
-389,744
-30% -$12.5M 0.42% 60
2015
Q2 		$41.1M Sell
1,290,527
-6,483
-0.5% -$211K 0.62% 35
2015
Q1 		$42.8M Sell
1,297,010
-1,759
-0.1% -$55.9K 0.65% 30
2014
Q4 		$38.4M Sell
1,298,769
-311,549
-19% -$8.93M 0.58% 43
2014
Q3 		$45.2M Buy
1,610,318
+72,808
+5% +$2.04M 0.78% 20
2014
Q2 		$43.3M Buy
1,537,510
+129,289
+9% +$3.69M 0.81% 16
2014
Q1 		$42.9M Buy
1,408,221
+477,694
+51% +$14.2M 0.94% 14
2013
Q4 		$27M Buy
930,527
+166,430
+22% +$4.84M 0.72% 25
2013
Q3 		$20.8M Buy
764,097
+5,586
+0.7% +$152K 0.68% 37
2013
Q2 		$20.2M Buy
+758,511
New +$21M 0.67% 36

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Riverhead Capital Management's PFE Position: Q3 2019 in Review

Riverhead Capital Management reduced its Pfizer (PFE) stake by 18% in Q3 2019, selling an estimated $3.71M and leaving 465,403 shares worth $15.9M. The position accounts for 0.59% of the portfolio, ranked #22.

Riverhead Capital Management first reported a position in PFE in Q2 2013 and has held it in 26 quarters since. The position peaked at $45.2M in Q3 2014. 2,323 funds tracked by Wall St. Rank hold PFE as of Q3 2019.

  • Riverhead Capital Management held 465,403 shares of Pfizer worth $15.9M as of Q3 2019.
  • Riverhead Capital Management sold 101,960 Pfizer shares in Q3 2019, an estimated $3.71M.
  • Pfizer made up 0.59% of Riverhead Capital Management's portfolio in Q3 2019, its #22 holding.
  • Riverhead Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 26 quarters since.
  • Riverhead Capital Management's Pfizer position peaked at $45.2M in Q3 2014.
  • 2,323 funds tracked by Wall St. Rank held Pfizer as of Q3 2019.

Based on Riverhead Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.